NAUTILUS BIOTECHNOLOGY INC (NAUT) Stock Cash Flow
NASDAQ:NAUT - Nasdaq - US63909J1088 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -68.66M | -70.78M | -63.67M | -57.92M | -50.32M | |||
| Depreciation Amortization | 1.92M | 1.98M | 1.85M | 1.22M | 1.02M | |||
| Change In Working Capital | -4.54M | -5.46M | -3.22M | -790.00K | -20.00K | |||
| Other non cash items | 14.47M | 15.12M | 13.33M | 11.69M | 10.08M | |||
| OPERATING CASH FLOW | -56.82M | -59.15M | -51.71M | -45.81M | -39.24M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.69M | -2.12M | -2.44M | -2.32M | -2.27M | |||
| Other Investing Activity | 65.10M | 68.37M | -41.29M | -23.42M | -136.70M | |||
| INVESTING CASH FLOW | 63.41M | 66.25M | -43.73M | -25.74M | -138.96M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 917.00K | 1.14M | 368.00K | 560.00K | 170.00K | |||
| Other Financing Activity | N/A | N/A | N/A | 0.00 | 327.28M | |||
| FINANCING CASH FLOW | 917.00K | 1.14M | 368.00K | 560.00K | 327.45M | |||
| CHANGE IN CASH | 7.51M | 8.25M | -95.08M | -70.99M | 149.25M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -56.82M | -59.15M | -51.71M | -45.81M | -39.24M | |||
| Capital Expenditure | -1.69M | -2.12M | -2.44M | -2.32M | -2.27M | |||
| FREE CASH FLOW | -58.51M | -61.27M | -54.15M | -48.13M | -41.51M | |||
All data in USD